Boston Scientific Corporation
$78.74B- Market cap
- $69.27B
- Debt
- +$11.44B
- Cash
- −$1.97B
Capital structure 86% equity / 14% debt · EV / Revenue 3.92x · EV / EBITDA 14.53x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
BSX · current priceP/E 24.64x
$47.80Latest market snapshot
Implied fair value · at BKH's multiple
$35.7025.3% below market
1.94 BSX EPS (TTM)×18.40x BKH P/E=$35.70
Market $47.80Implied $35.70
BKH · current priceP/E 18.40x
$73.23Latest market snapshot
Implied fair value · at BSX's multiple
$98.0633.9% above market
3.98 BKH EPS (TTM)×24.64x BSX P/E=$98.06
Market $73.23Implied $98.06